• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用慢病毒载体进行基因转移的伦理考量。

Ethical considerations in the use of lentiviral vectors for genetic transfer.

作者信息

Roy I

机构信息

Center for Bioethics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

出版信息

Somat Cell Mol Genet. 2001 Nov;26(1-6):175-91. doi: 10.1023/a:1021086915922.

DOI:10.1023/a:1021086915922
PMID:12465468
Abstract

This chapter will outline the various concerns which have been raised in scientific, bioethics, and lay communities about the use of lentiviral vectors for purposes of gene therapy. Many of these concerns are ranged around gene therapy itself; others are concerns particular to using this sort of vector for genetic modification of human cells. These concerns are outlined within the chapter, and arguments are given in favor and against various approaches to these concerns. Lastly, it is noted throughout that at this stage of research into gene therapy, the most practical approach to these dilemmas is to maintain awareness of the ethical problems and provide information to those concerned with all aspects of the development of this set of technologies.

摘要

本章将概述科学界、生物伦理学界以及普通大众针对将慢病毒载体用于基因治疗目的所提出的各种担忧。其中许多担忧围绕基因治疗本身;其他则是关于使用这类载体对人类细胞进行基因改造的特定担忧。本章将对这些担忧进行概述,并给出支持和反对针对这些担忧的各种处理方法的论据。最后,需要指出的是,在基因治疗的现阶段研究中,应对这些困境最切实可行的方法是保持对伦理问题的认识,并向关注这一系列技术发展各个方面的人士提供相关信息。

相似文献

1
Ethical considerations in the use of lentiviral vectors for genetic transfer.使用慢病毒载体进行基因转移的伦理考量。
Somat Cell Mol Genet. 2001 Nov;26(1-6):175-91. doi: 10.1023/a:1021086915922.
2
Safety considerations in vector development.载体开发中的安全考量
Somat Cell Mol Genet. 2001 Nov;26(1-6):147-58. doi: 10.1023/a:1021082815013.
3
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector.新型基因治疗产品的监管考量:首个临床慢病毒载体研发过程综述
Hum Gene Ther. 2005 Jan;16(1):17-25. doi: 10.1089/hum.2005.16.17.
4
Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products.首个世界卫生组织慢病毒载体标准的制定:迈向基于慢病毒的基因治疗产品的生产控制与标准化
Hum Gene Ther Methods. 2017 Aug;28(4):205-214. doi: 10.1089/hgtb.2017.078.
5
The inside out of lentiviral vectors.慢病毒载体的内部结构。
Viruses. 2011 Feb;3(2):132-159. doi: 10.3390/v3020132. Epub 2011 Feb 14.
6
Lentiviral vectors and gene therapy.慢病毒载体与基因治疗。
Front Biosci. 1999 Jun 1;4:D481-96. doi: 10.2741/klimatcheva.
7
High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.用于基因和细胞治疗的滚瓶中基于HIV的慢病毒载体的高滴度生产。
Methods Mol Biol. 2019;1879:323-345. doi: 10.1007/7651_2018_150.
8
Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.使用逆转录病毒和慢病毒载体对造血细胞进行基因改造:载体设计及导入靶细胞的安全性考量
Curr Hematol Rep. 2005 Jul;4(4):300-4.
9
[Lentiviral vectors].[慢病毒载体]
Mol Biol (Mosk). 2008 Sep-Oct;42(5):913-26.
10
Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.慢病毒载体:用于实验性基因转移的优秀工具及基因治疗的有前景候选者。
J Gene Med. 2000 Sep-Oct;2(5):308-16. doi: 10.1002/1521-2254(200009/10)2:5<308::AID-JGM131>3.0.CO;2-3.